Asr Vermogensbeheer N.V. Alnylam Pharmaceuticals, Inc. Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 8,876 shares of ALNY stock, worth $3.93 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,876
Previous 8,926
0.56%
Holding current value
$3.93 Million
Previous $2.91 Billion
39.06%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
830Shares Held
118MCall Options Held
584KPut Options Held
648K-
Capital World Investors Los Angeles, CA16.8MShares$7.44 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.01 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.23 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.18 Billion0.49% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.01 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $54.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...